Costing of diabetes mellitus type II in Cambodia

Health Economics Review

Volumn 4, Issue 1, 2014, Pages 1-15

  Flessa, Steffen ^a   Zembok, Anika ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Cambodia; Costing; Diabetes; Markov Model; Prediction; South East Asia; T2DM

Indexed keywords

ORAL ANTIDIABETIC AGENT;

ARTICLE; DEATH; DECISION MAKING; DRUG COST; ECONOMIC ASPECT; FUNDING; HEALTH CARE COST; HEALTH ECONOMICS; HIDDEN MARKOV MODEL; HUMAN; INCIDENCE; INSULIN TREATMENT; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SIMULATION;

EID: 84971255248     PISSN: None     EISSN: 21911991     Source Type: Journal    
DOI: 10.1186/s13561-014-0024-4     Document Type: Article

References (59)

1. IDF Diabetes Atlas., [http://www.idf.org/diabetesatlas/FAQs]
2. Diabetes., [http://www.who.int/mediacentre/factsheets/fs312/en/]
3. Disease and injury regional mortality estimates, 2000–2011., [http://www.who.int/healthinfo/global_burden_disease/estimates_regional/en/index.html]
4. Meade M, Emch M: Medical Geography. The Guilford Press, New York, London; 2005.
5. Prevalence of non-communicable disease risk factors in Cambodia. STEPS Survey Country Report 2010. Royal Government of Cambodia, Phnom Penh; 2010.
6. King H, Keuky L, Seng S, Khun T, Roglic G, Pinget M: Diabetes and associated disorders in Cambodia: two epidemiological surveys. Lancet 2005, 366: 1633–1639. 10.1016/S0140-6736(05)67662-3
7. Burden of Disease Database., [http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/index.html]
8. IDF DIABETES ATLAS. IDF, Brussels; 2014.
9. Soewondo P, Ferrario A, Tahapary DL: Challenges in diabetes management in Indonesia: a literature review. Globalization and health 2013, 9: 63. 10.1186/1744-8603-9-63
10. Andayani T, Imaningsih I: Cost analysis of antidiabetic drugs for diabetes mellitus outpatient in Kodya Yogyakarta Hospital. Malay J Phar Sci 2007, 5: 19–23.
11. Andayani T: Cost analysis of diabetes mellitus therapy in Dr. Sardjito hospital Yogyakarta. Maj Farm Indones 2006, 17: 130–135.
12. WP SE, Azimatun N, Amrizal M, Rohaizan J, Saperi B: Economic burden of diabetic care in government health facilities in Selangor. Jurnal Kesihatan Masyarakat 2009, 15: 17–26.
13. Ibrahim SS, Sulaiman SAS, Gillani SW, Hassali MA, Abougalambou ASI, Mohamed M: Evaluation of direct medical cost among outpatients of type 2 diabetes mellitus: cost analysis in teaching hospital of Malaysia. Folia Medica Facultatis Medicinae Universitatis Saraeviensis 2010, 45:.
14. Beran D, Higuchi M: Delivering Diabetes Care in the Philippines and Vietnam Policy and Practice Issues. Asia Pac J Public Health 2013, 25: 92–101. 10.1177/1010539511412177
15. Higuchi M: Costs, availability and affordability of diabetes care in the Philippines. 2009.
16. Higuchi M: Access to diabetes care and medicines in the Philippines. Asia Pac J Public Health 2010, 22: 96S-102S. 10.1177/1010539510373005
17. Chatterjee S, Riewpaiboon A, Piyauthakit P, Riewpaiboon W, Boupaijit K, Panpuwong N, Archavanuntagul V: Cost of diabetes and its complications in Thailand: a complete picture of economic burden. Health Soc Care Community 2011, 19: 289–298. 10.1111/j.1365-2524.2010.00981.x
18. World Diabetes Foundation: Program Evaluation - Creating a model for diabetes health care services in provincial level in Cambodia. In Book Program Evaluation - Creating a model for diabetes health care services in provincial level in Cambodia. World Diabetes Foundation.
19. Raguenaud M-E, Isaakidis P, Reid T, Chy S, Keuky L, Arellano G, van Damme W: Treating 4,000 diabetic patients in Cambodia, a high-prevalence but resource-limited setting: a 5-year study. BMC Medicine 2009, 7:.
20. World Development Indicators 2014. The World Bank Press, Washington D.C; 2014.
21. Cambodian Demographic Health Survey and Cambodia Socio-Economic Surveys Analysis. Kingdom of Cambodia, Phnom Penh; 2011.
22. National Strategic Plan for the Prevention and Control of Noncommunicable Diseases. Ministry of Health, Phnom Penh; 2014.
23. van Pelt M, Lucas H, Men C: Yes, they can. In Transforming Health Markets in Asia and Africa: Improving Quality and Access for the Poor. Edited by Bloom G, Kanjilal B, Lucas H, Peters DH. Routledge; 2012:115.
24. von der Schulenburg J-MG, Greiner W, Jost F, Klusen N, Kubin M, Leidl R, Mittendorf T, Rebscher H, Schöffski O, Vauth C: Deutsche Empfehlungen zur gesundheitsökonomischen Evaluation. Prӓsidium ab 1 Januar 2008 2007, 23.
25. Tarride J-E, Hopkins R, Blackhouse G, Bowen JM, Bischof M, Von Keyserlingk C, O'Reilly D, Xie F, Goeree R: A review of methods used in long-term cost-effectiveness models of diabetes mellitus treatment. Pharmacoeconomics 2010, 28: 255–277. 10.2165/11531590-000000000-00000
26. Liu X, Li C, Gong H, Cui Z, Fan L, Yu W, Zhang C, Ma J: An economic evaluation for prevention of diabetes mellitus in a developing country: a modelling study. BMC Public Health 2013, 13: 1–11. 10.1186/1471-2458-13-1
27. Life tables Cambodia: Excel-Tabelle., [http://apps.who.int/gho/data/view.main.60270]
28. Wilke T, Ahrendt P, Schwartz D, Linder R, Ahrens S, Verheyen F: Inzidenz und Prӓvalenz von Diabetes mellitus Typ 2 in Deutschland. Dtsch Med Wochenschr 2013, 138: 69–75. 10.1055/s-0032-1327394
29. Ringborg A, Lindgren P, Yin DD, Martinell M, Stålhammar J: Time to insulin treatment and factors associated with insulin prescription in Swedish patients with type 2 diabetes. Diabetes Metab 2010, 36: 198–203. 10.1016/j.diabet.2009.11.006
30. MoPoTsyo patient information centre: Annual report 2011 In Book MoPoTsyo patient information centre: Annual report 2011. MoPoTsyo Patient Information Centre, City; 2012.
31. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 1998, 352: 837–853. 10.1016/S0140-6736(98)07019-6
32. Ballard DJ, Humphrey LL, Melton LJ, Frohnert PP, Chu PC, O'Fallon WM, Palumbo PJ: Epidemiology of persistent proteinuria in type II diabetes mellitus Population-based study in Rochester, Minnesota. Diabetes 1988, 37: 405–412. 10.2337/diab.37.4.405
33. Ahmed KR: Incidence of diabetic retinopathy: A 15 year follow-up in a hospital population (Bangladesh). In Masterarbeit. Universitӓt von Oslo; 2009.
34. Sands ML, Shetterly SM, Franklin GM, Hamman RF: Incidence of distal symmetric (sensory) neuropathy in NIDDM. The San Luis Valley Diabetes Study Diabetes care 1997, 20: 322–329.
35. Mata-Cases M, Prado-Lacueva C, Salido-Valencia V, Fernández-Bertolín E, Casermeiro-Cortés J, García-Durán M, Jabalera-López S, Fernández-Sanmartín MI: Incidence of complications and mortality in a type 2 diabetes patient cohort study followed up from diagnosis in a primary healthcare centre. Int J Clin Pract 2011, 65: 299–307. 10.1111/j.1742-1241.2010.02503.x
36. van Pelt M: Diabetes situation in Cambodia: personal communication. In Book Diabetes situation in Cambodia: personal communication. MoPoTsyo Patient Information Centre, City; 2013.
37. WHO-CHOICE unit cost estimates for service delivery., [http://www.who.int/choice/country/country_specific/en/index.html]
38. Case study: Diabetes, Cambodia's silent killer., [http://www.capacity.org/capacity/opencms/en/topics/health-systems/accessible-care-for-diabetes-in-cambodia.html]
39. Frye JE: International drug price indicator guide: 2012 edition. In Book International drug price indicator guide. 2012th edition.
40. Martin A: Cambodia hospital costing and financial management study: Final Report. In Book Cambodia hospital costing and financial management study: Final Report. Ministry of Health, City; 2013.
41. Flessa S, Greiner W: Gesundheitsökonomik Eine Einföhrung in das wirtschaftliche Denken für Mediziner. Springer, Berlin; 2013.
42. Cambodian Demographic and Health Survey 2010. Royal Governement of Cambodia, Phnom Penh; 2010.
43. Loyo HK, Batcher C, Wile K, Huang P, Orenstein D, Milstein B: From model to action using a system dynamics model of chronic disease risks to align Community Action. Health Promot Pract 2013, 14: 53–61. 10.1177/1524839910390305
44. Khuwaja AK, Khowaja LA, Cosgrove P: The economic costs of diabetes in developing countries: some concerns and recommendations. Diabetologia 2010, 53: 389–390. 10.1007/s00125-009-1581-7
45. HPV Information Centre - Data Query., [http://www.hpvcentre.net/dataquery.php]
46. WHO: Comprehensive cervical cancer control: a guide to essential practice. World Health Organization; 2006.
47. Harris MI, Klein R, Welborn TA, Knuiman MW: Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care 1992, 15: 815–819. 10.2337/diacare.15.7.815
48. Cheng S-H, Chen C-C, Tseng C-H: Does medication adherence lead to lower healthcare expenses for patients with diabetes? Am J Manag Care 2013, 19: 662–670.
49. Cambodia M: Clinical Practice Guidelines Type 2 Diabetes. In Book Clinical Practice Guidelines Type 2 Diabetes. City: 2013.
50. Lane PA: The state of the Tanzanian economy 1984. In Book The state of the Tanzanian economy 1984. City: 1984.
51. IDF Diabetes Atlas 5th Edition: Country Estimates Table 2030., [https://www.idf.org/sites/default/files/IDFAtlas5E_Detailed_Estimates_0.xls]
52. Martin A: Cambodia Hospital Costing and Financial Management Study. National Social Security Fund, Phnom Penh; 2012.
53. Atwood B: Development Co-operation Report 2012: Lessons in Linking Sustainability and Development. OECD Publishing, Paris; 2014.
54. World Data Bank. [http://www.databank.worldbank.org]
55. Davies MJ, Williams D, Metcalf J, Day DL: Community screening for non-insulin-dependent diabetes mellitus: self testing for post-prandial glycosuria. Q J Med 1993, 86: 677–684. 10.1093/qjmed/86.10.677
56. Hanson RL, Nelson RG, McCance DR, Beart JA, Charles MAN, Pettitt DJ: Community screening for non-insulin-dependent diabetes mellitus: self testing for post-prandial glycosuria. QJ Medicine 1993, 86: 2133–2140.
57. Friderichsen B, Maunsbach M: Glycosuric tests should not be employed in population screening. J Public Health Med 1997, 19: 55–60. 10.1093/oxfordjournals.pubmed.a024588
58. Shinozaki T, Yamaoka K, Yano E: [Validity of urinary glucose test for diabetes screening in workplace regular medical checkups]. [Nihon koshu eisei zasshi] Japanese journal of public health 1999, 46: 790–798.
59. WHO: Screening for type 2 diabetes: report of a World Health Organization and International Diabetes Federation meeting. Geneva: 2003.